Lundbeck has entered into a partnership with Swixx Group to continue bringing our medicines to patients and healthcare professionals in Israel.

Continuity of care remains our top priority. Together with Swixx, we are ensuring access to Lundbeck’s medicines and ongoing support for patients and healthcare professionals.

Swixx shares Lundbeck’s commitment to improving brain health and has the local expertise and infrastructure to ensure smooth, reliable delivery of our treatments.

Read the official announcement here.

For more information about Swixx, please visit the Swixx website or contact info@swixxbiopharma.com.

For patients/carers or healthcare professionals seeking to report adverse events or submit product quality complaints, please contact israel.info@swixxbiopharma.com.

If you want to submit a medical enquiry, please contact israel.info@swixxbiopharma.com.

To learn more about Lundbeck globally, visit Lundbeck.com.